18 articles
Delhi High Court reviews whether the Controller of Patents could refuse Fresenius Kabi Ipsum Srl's sugammadex process patent without a separate Section 14 hearing, despite hearing a competitor's…
The Office of the Controller General of Patents, Designs & Trade Marks (CGPDTM) has released Draft Guidelines for Examination of Patent Applications in the Field of Pharmaceuticals, 2026…
Crocs Inc. USA and M/S Bata India Ltd. fought over a footwear design for over a decade before the Delhi High Court. After Crocs' design registration was cancelled…
Voicemonk Patent prevails over Flipkart in a key patent dispute, clarifying novelty, inventive step, and Section 3(k) under Indian patent law
Madras HC upholds CRI patentability in Syngene’s case, ruling novel hardware isn’t a prerequisite for protection under Section 3(k).
The Delhi High Court’s analysis in Ericsson vs. Lava addresses the novelty and inventive step of key standard essential patents for 3G and EDGE technology. This post summarises…
This article provides a detailed analysis of the novelty and inventive step of Ericsson’s AMR patents as examined in Ericsson Vs. Lava. The Delhi High Court’s findings illustrate…
This post reviews three High Court decisions reversing unreasoned patent refusals in India, focusing on Section 3(d), novelty, and inventive step. The courts stressed the need for considering…
This post explores the five patentability requirements under Indian law, including subject matter, novelty, inventive step, industrial applicability, and specification. It discusses statutory provisions, key case law, and…
The post provides a detailed analysis of the criteria for patentability of biotechnology inventions in India, focusing on statutory exclusions and legal requirements. It further outlines how industrial…